梅斯医学专访SJVF血管病论坛主席陆信武教授:医学继续教育迫在眉睫

2016-06-04 MedSci MedSci原创

第五届上海交通大学血管病论坛(AJVF2016)于2016年6月3-5日在上海隆重举行。SJVF已成为中国血管外科领域最具影响力的学术交流平台之一。本届SJVF由上海交通大学医学院附属第九人民医院承办。大会执行主席陆信武教授带来了“累及弓部分支的主动脉疾病的激光原位开窗术”治疗经验。梅斯医学作为媒体合作单位,为您发来现场报告。 专家简介: 陆信武,主任医师,

第五届上海交通大学血管病论坛(SJVF2016)于2016年6月3-5日在上海隆重举行。SJVF已成为中国血管外科领域最具影响力的学术交流平台之一。本届SJVF由上海交通大学医学院附属第九人民医院承办。大会执行主席陆信武教授带来了“累及弓部分支的主动脉疾病的激光原位开窗术”治疗经验。梅斯医学作为媒体合作单位,为您发来现场报告。




专家简介:

陆信武,主任医师,教授,博士生导师。血管外科主任,上海交通大学血管病诊治中心常务副主任。参与编写专著5部,目前被聘为中华医学会整形外科分会血管瘤与脉管畸形学组委员,中华医学会医学工程学分会血管外科与组织工程专业委员会委员等多项职位,担任多个期刊审稿人。

2000年获教育部科技进步三等奖1项,2004年获上海市医学科技成果三等奖1项;2007年获中华医学科技成果三等奖、上海市科学技术奖三等奖和上海市医学科技成果二等奖各一项;2009年获上海市科学技术奖三等奖和上海市医学科技成果二等奖各一项。受首批上海第二医科大学“百人计划”资助,2013年在德国莱比锡大学花园医院研修。

正文:

主动脉夹层累及弓部分支的腔内治疗一直是血管外科的热门话题。由于涉及到颈动脉、锁骨下动脉血流的重建,无论是解剖学、血流动力学、手术设计及器材上均面临极大的风险与挑战,一旦出现意外,患者可能因脑部缺血引起脑梗,严重者面临生命危险,主动脉弓部区域长期以来一直被视为难以逾越的腔内治疗禁区。

上海第九人民医学院血管外科团队采用国际领先的激光原位开窗技术(Laser-assisted in-situ fenestration),对累及弓部分支的B型主动脉夹层行颈动脉/锁骨下动脉原位开窗TEVAR治疗,在封闭夹层破口的同时快速重建受夹层累及的弓部分支动脉,不仅免去了传统开放手术创伤大风险高等缺点,更是极大推动了主动脉夹层全腔内治疗的进程。

九院血管外科累计完成主动脉夹层激光原位开窗术17例,技术成功率94%,围手术期分支动脉缺血并发症发生率0%。该项技术在2016年6月3-5日举行的上海交通大学血管病论坛(SJVF)上,以手术录播和三维动画教程的方式进行推广和传播,以期为更多的主动脉夹层患者带来福音。

以下为梅斯医学专访内容:



此次血管病论坛的亮点和新关注点

陆信武教授:交通大学血管病论坛在前四届都是由九院血管外科独立举办,此次会议由血管病诊治中心相关的6家合作单位联合举办。此次会议秉承一贯的办会宗旨,以病例为导向,通过病例对临床问题进行深入讨论,试图从讨论中对专家共识和临床问题进行深入交流。此次会议的创新在于对一些新的技术方法的介绍,如在大动脉领域:原位开窗、分支支架、平行支架等最新的技术介绍;在静脉领域,对静脉回流障碍疾病治疗、血栓后遗症的治疗和新发血栓的治疗的进展介绍;对动脉闭塞性疾病的基本处理达成共识,以期给患者带来最大的获益。

此次会议开设了专门的血管外科干预糖尿病足的论坛,而以往糖尿病的治疗通常以内分泌科为主,那么血管外科在糖尿病足的治疗中有哪些优势和关注点呢?

陆信武教授:糖尿病足首先是由于糖尿病导致的足病,以往常见于内分泌科的患者。血管外科高度关注糖尿病的原因是由于糖尿病患者发生血管病变的几率远高于正常人群。血管外科的介入往往能改善治疗效果。例如,对于糖尿病足合并血管病变的患者,血管外科干预在改善血供的情况下,结合基础的足病的处理可以产生更好的效果。内分泌科医生更多关注的是足病的本身,如,感染、神经性疾病、溃烂、对于创面的处理等,但很少关注引起足病的原因。而血管病变是引起糖尿病足的重要原因,因此血管外科的干预往往可明显改善治疗效果,为糖尿病足的综合治疗带来益处。
 
血管外科作为一个新兴学科,但其发展和普及的速度非常迅速。上海在血管外科的发展和继续教育上都处于领先地位,对基层医院血管外科的发展和医学继续教育有哪些建议呢?

陆信武教授:血管外科作为一个新兴的学科,有着非常重要的作用,而在大学时期,教科书对于血管外科疾病的介绍极少,在临床工作中也很难回忆起课本内容,血管外科疾病的再教育是迫在眉睫的事情。上海在血管外科的发展和医学继续教育上有着领先的水平,而基层医生对于血管外科疾病的认识可能局限于静脉性疾病,如静脉曲张这类简单性病变的认识,这里需要国家和大医院的医生们深入基层,做好继续教育,使更多的血管性疾病患者得到及时有效的治疗。

互联网对于医学继续教育的作用和建议

陆信武教授:首先要肯定互联网对于医学继续教育的积极作用。我们血管外科每年会进行10-15次的学习班,通过直播可以使更多的医生得到教育,增加直接交流的机会,并减少成本。互联网对于医学继续教育有着重要的作用,相信会得到更好的发展。

很多血管外科疾病的患者并不是首诊于血管外科,往往由由各个科室转诊而来,对各个科室医生如何尽快认识到血管外科疾病并进行转诊的建议

陆信武教授:由于大学教育对血管外科疾病的介绍很少,很多临床医生对血管外科疾病的认识不足,使得血管外科疾病转诊的现状不是很理想。其他科室的临床医生应加强对血管外科疾病知识的理解,能够尽快将患者进行转诊;同样,患者也应加强对简单的血管疾病的认识,使自己及时得到诊治。因此,对于临床医生和普通群众的继续教育都是很重要的。

血管外科疾病往往是全身性的疾病,在外科治疗的同时需要进行内科的干预。对临床医生的临床知识和手术技巧要求较高,那对年轻医生提出了哪些要求呢?

陆信武教授:血管外科疾病确实往往是全身性的疾病,尤其是动脉性疾病,常合并很多心脑血管疾病。因此,血管外科医生不仅要掌握开放手术技巧,也要掌握介入和腔内治疗的技术,同时要掌握基础的疾病处理;对于一些复杂的内科疾病,需要同内科医生共同探讨,将患者的情况调整到最佳干预状态。

真实世界研究证据与血管领域研究动态

在6月5日(本周日)上午,在会议室7(分会场4),梅斯医学将会为各位呈现一场关于血管领域的真实世界研究的精彩演讲!为回报各位粉丝对梅斯医学的厚爱,我们提供了20个免费参会名额赠送给各位!



获取免费名额请关注梅斯医学APP

关于梅斯医学

梅斯医学(MedSci)是中国领先的医生互联网平台,拥有超过120万注册医生用户,主要从事临床研究、医生继续教育和培训,以及智慧医疗服务,旨在推动和加速临床医生的职业成长,改善医疗质量。



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
    2016-10-31 马龙
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
    2016-06-16 busylazy

    有能力有想法

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
    2016-06-05 沉心多思

    不错的文章,多学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
    2016-06-05 一闲
  8. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
    2016-06-05 沉心多思

    不错的文章,多学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1644483, encodeId=0d0016444838c, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Dec 03 23:34:00 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076150, encodeId=73de20e6150c3, content=<a href='/topic/show?id=e3279e985cf' target=_blank style='color:#2F92EE;'>#陆信武#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97985, encryptionId=e3279e985cf, topicName=陆信武)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Oct 31 09:34:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941668, encodeId=7977194166883, content=<a href='/topic/show?id=e970e89890c' target=_blank style='color:#2F92EE;'>#继续教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78989, encryptionId=e970e89890c, topicName=继续教育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Wed Jul 20 11:34:00 CST 2016, time=2016-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703216, encodeId=f6ae1e032168c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Wed Jun 22 02:34:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90046, encodeId=dd1d90046d2, content=有能力有想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/23/37e4e361e5906156dbe2878394fce900.jpg, createdBy=00c476551, createdName=busylazy, createdTime=Thu Jun 16 19:55:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88648, encodeId=cb0b8864847, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 21:15:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276822, encodeId=293112e6822d3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jun 05 16:34:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88522, encodeId=812788522b7, content=不错的文章,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Sun Jun 05 14:49:00 CST 2016, time=2016-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88413, encodeId=687788413af, content=牛人一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat Jun 04 09:17:00 CST 2016, time=2016-06-04, status=1, ipAttribution=)]
    2016-06-04 忠诚向上

    牛人一个

    0